IGFBP-3

IGFBP-3 분자 정보

영어 이름Insulin-like growth factor binding protein III시판 약물 수0
임상 약물 수2표적 별명
최고 연구 개발 단계Phase 2 Clinical
영어 이름Insulin-like growth factor binding protein III
표적 별명
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 2 Clinical

IGFBP-3 제품 목록

  • 속성

    Protein (2)

  • 제품 라이브러리

    온라인 (2)

  • Human (2)

  • 태그

    His Tag (1)Fc Tag (1)

  • 마커

    Unconjugated (2)

제품 번호발현 시스템제품 설명단백질 구조순도특성
IG3-H5253
Human
HEK293
Human IGFBP-3 (28-291) Protein, Fc Tag
IG3-H52H9
Human
HEK293
Human IGFBP-3 Protein, His Tag
총 수량2
  • 1

IGFBP-3분자 배경

Insulin-like growth factor-binding protein 3 is also known as IGFBP3, is a protein that, in humans, is encoded by the IGFBP3 gene. IGFBP3 forms a ternary complex of about 140 ~150 kDa with IGF1 or IGF2 and a glycoprotein insulin-like growth factor acid-labile subunit (ALS), thus alter the interaction of IGFs with their cell surface receptors. IGFBP3 exerts either proapoptotic or growth stimulatory effects depending upon the cellular context. Studies have shown that IGFBP3 can leads to the induction of apoptosis dependent or independent of the IGF-IGF receptor axis, accordingly acts as a negative regulator of tumorigenesis and progressing in certain carcinomas. The highest expression level is found in the nonparanchymal cells of the liver. Expression levels are also higher during extrauterine life and peak during puberty.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Mecasermin RinfabaterhIGF-I/rhIGFBP-3; TAK-607; OHB-607; IGF-I/IGFBP-3; SHP-607; HGT-ROP-001Phase 2 ClinicalInsmedBronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Failure to Thrive; Laron Syndrome; Lung Diseases; Myotonic Dystrophy; Noonan Syndrome; Retinopathy of Prematurity
상세
ENT-001Ent-001; ENT-001; Ent001Phase 1 ClinicalOspedale San RaffaeleDiabetes Mellitus, Type 1; Inflammatory Bowel Diseases
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호